Seattle, WA, United States of America

Katherine E Henderson

USPTO Granted Patents = 4 


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2006-2014

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Katherine E Henderson: Innovator in Viral Infection Treatment

Introduction

Katherine E Henderson is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of antiviral treatments, holding a total of four patents. Her work focuses on innovative methods for treating viral infections, particularly those affecting the liver.

Latest Patents

Henderson's latest patents include groundbreaking methods for treating viral infections using IL-28 and IL-29 cysteine mutants. These mutants have demonstrated antiviral activity against a range of viral species, with a particular emphasis on hepatitis B and C viruses. Notably, IL-28A, IL-28B, and IL-29 do not exhibit the antiproliferative activity on hematopoietic cells that is typically associated with interferon treatments. This characteristic makes them particularly useful for treating immunocompromised patients without the immunosuppressive effects of interferon.

Another significant patent involves the use of IL-29 for treating dengue virus infections. Similar to her other patents, this work highlights the antiviral potential of IL-28A, IL-28B, IL-29, and their mutants against various viral species.

Career Highlights

Throughout her career, Katherine has worked with notable companies such as Zymogenetics, Inc. and Bristol-Myers Squibb Company. Her experience in these organizations has allowed her to develop and refine her innovative approaches to viral infection treatment.

Collaborations

Katherine has collaborated with esteemed colleagues, including Kevin M Klucher and Pallavur V Sivakumar. These partnerships have contributed to her success in the field of antiviral research.

Conclusion

Katherine E Henderson is a trailblazer in the development of antiviral treatments, with a focus on innovative methods that improve patient outcomes. Her contributions to the field are invaluable, and her work continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…